{
  "data": [
    {
      "projectCode": "D9470",
      "dxName": "Name: BCKDKS; \r\nTitle: Reduction of morbidity and mortality by daily oral administration of a  small molecule BCKDK inhibitor in patients with diabetic or non-diabetic HF with Reduced Ejection Fraction (HFrEF)-VaxEquity collaboration for all cross-functional time bookings",
      "dxTitle": "CD123 Topo ADC",
      "status": "ACTIVE",
      "phaseCode": "PH1",
      "category": "DRUG"
    },
    {
      "projectCode": "R0656",
      "dxName": "Name: 12DNF1; Title: Inhibitors of RAS G12D with NF1: Development of QW SC GLP-1R/GCGR dual agonist peptide for treatment of T2D, with potential for NASH and obesity indications. \r\n Post-Graduate Research Activities in Personalised Healthcare & Biomarkers (PHB)",
      "dxTitle": "Inhibitors of RAS G12D with NF1: Development of QW SC GLP-1R/GCGR dual agonist peptide for treatment of T2D, with potential for NASH and obesity indications.",
      "status": "ACTIVE",
      "phaseCode": "TV",
      "category": "DRUG"
    }
  ]
}